Peptides/Semaglutide
Semaglutide
Metabolicstrong evidence

Semaglutide

GLP-1 agonist for metabolic optimization

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist originally developed for type 2 diabetes. It has become widely known for its dramatic effects on weight management and is FDA-approved under brand names Ozempic and Wegovy.

⚙️ Mechanism of Action

Semaglutide mimics the GLP-1 hormone, stimulating insulin secretion, suppressing glucagon, slowing gastric emptying, and acting on brain appetite centers to reduce hunger and caloric intake.

Benefits

  • Significant weight loss (15–20% body weight)
  • Improved glycemic control
  • Cardiovascular risk reduction
  • Reduced systemic inflammation
  • Potential neuroprotective effects

⚠️ Risks & Considerations

  • Nausea, vomiting, diarrhea (common initial side effects)
  • Pancreatitis risk (rare)
  • Gallbladder issues
  • Muscle mass loss without resistance training
  • Thyroid C-cell tumor risk (animal studies)
🧬PeptidesAgent

⚠️ For informational purposes only. Not medical advice. Always consult a qualified healthcare provider before using any peptide or supplement.

© 2026 PeptidesAgent·Admin

PeptidesAgent

Usually replies instantly

Hi there! 👋

Ask me anything about peptides, dosing protocols, or stacks.

For research purposes only · Not medical advice